A Raia Drogasil SA – B3: RADL3 had a positive performance in the third quarter of 2023, with gross revenue of R$9,288 million,

representing a growth of 16.3% compared to the same period of the previous year. Gross profit remained stable at 27.9% gross margin . Adjusted EBITDA grew 20.4%, reaching R$658.1 million. Adjusted net profit also grew significantly by 33.1%, totaling R$268.4 million.

The company presented a positive free cash flow of R$336.2 million

and a total cash generation of R$263.1 million. Resources from operations totaled R$501.7 million, equivalent to 5.4% of gross revenue. Furthermore, they recorded R$174.0 million in working capital, which resulted in an operating cash flow of R$675.7 million, more than enough to finance the CAPEX of R$339.5 million for the period.

The company's adjusted net debt ended the third quarter at R$2,644.3 million,

representing a leverage of 1.0 times the adjusted EBITDA of the last 12 months.

In the last line of the Income Statement (DRE ), RaiaDrogasil presented an adjusted net profit of R$268 million, which represents an increase compared to the same quarter of the previous year, but a decrease compared to the previous quarter.

Is this growth enough to justify the company's Valuation multiples? Tell the analyst.

Investidor avançado